# Celularity Inc: filings

CELU · Nasdaq · CIK 1752828 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/celu.md) · [Financials](/companies/celu/financials.md) · [Filings](/companies/celu/filings.md) · [Insiders](/companies/celu/insiders.md)

## Reports and events: 184 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 145, 8-K 119, 3 36, 424B3 33, 10-Q 22, 425 20, CORRESP 16, SC 13G 16, UPLOAD 13, EFFECT 12, SC 13G/A 11, 4/A 9, NT 10-Q 9, 10-K 7, DEF 14A 7, S-1 7, SCHEDULE 13D/A 6, D 5, 10-K/A 4, 424B5 4, PRE 14A 4, S-4/A 4, 8-K/A 3, DEFA14A 3, NT 10-K 3, POS AM 3, S-1/A 3, S-8 3, SC 13D/A 3, 25-NSE 2, ARS 2, RW 2, S-3 2, SC 13D 2, SEC STAFF LETTER 2, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, FWP 1, S-4 1, SCHEDULE 13D 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 17:08 ET | [10-Q](/filings/0001493152-26-047787.md) | Quarterly report, period 2026-06-30 | 0001493152-26-047787 |
| 2026-10-20 | 09:15 ET | [10-K/A](/filings/0001493152-26-047708.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-047708 |
| 2026-09-29 | 17:25 ET | [8-K](/filings/0001493152-26-044917.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-044917 |
| 2026-09-29 | 17:02 ET | [10-Q](/filings/0001493152-26-044892.md) | Quarterly report, period 2026-03-31 | 0001493152-26-044892 |
| 2026-09-28 | 13:14 ET | [SCHEDULE 13D/A](/filings/0001104659-26-111279.md) | Ownership report, active investor, amended | 0001104659-26-111279 |
| 2026-09-28 | 06:14 ET | [8-K](/filings/0001493152-26-044421.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-044421 |
| 2026-09-14 | 09:00 ET | [8-K](/filings/0001493152-26-042495.md) | 8.01 Other events | 0001493152-26-042495 |
| 2026-08-07 | 17:10 ET | [8-K](/filings/0001493152-26-036648.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-036648 |
| 2026-07-29 | 16:15 ET | [8-K](/filings/0001493152-26-035193.md) | 3.01 Delisting notice | 0001493152-26-035193 |
| 2026-06-30 | 09:00 ET | [8-K](/filings/0001493152-26-031216.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-031216 |
| 2026-06-25 | 17:27 ET | [8-K](/filings/0001493152-26-030199.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-030199 |
| 2026-06-23 | 06:02 ET | [SCHEDULE 13D/A](/filings/0001104659-26-076580.md) | Ownership report, active investor, amended | 0001104659-26-076580 |
| 2026-06-12 | 17:15 ET | [8-K](/filings/0001493152-26-028519.md) | 3.01 Delisting notice | 0001493152-26-028519 |
| 2026-06-03 | 17:22 ET | [8-K](/filings/0001493152-26-027132.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027132 |
| 2026-05-28 | 16:54 ET | [8-K](/filings/0001493152-26-025646.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-025646 |
| 2026-04-30 | 16:06 ET | [10-K](/filings/0001493152-26-020424.md) | Annual report, period 2025-12-31 | 0001493152-26-020424 |
| 2026-04-22 | 10:16 ET | [SCHEDULE 13D/A](/filings/0001104659-26-046494.md) | Ownership report, active investor, amended | 0001104659-26-046494 |
| 2026-04-21 | 09:05 ET | [8-K](/filings/0001493152-26-018220.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-018220 |
| 2026-04-03 | 11:08 ET | [SCHEDULE 13D](/filings/0001104659-26-039490.md) | Ownership report, active investor | 0001104659-26-039490 |
| 2026-03-10 | 09:00 ET | [8-K](/filings/0001493152-26-009471.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-009471 |
| 2026-03-05 | 17:00 ET | [8-K](/filings/0001493152-26-009017.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-009017 |
| 2026-01-21 | 16:30 ET | [8-K](/filings/0001493152-26-003100.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-003100 |
| 2025-12-31 | 16:15 ET | [S-1](/filings/0001493152-25-029802.md) | Registration statement | 0001493152-25-029802 |
| 2025-12-23 | 16:15 ET | [8-K](/filings/0001493152-25-029033.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-029033 |
| 2025-12-19 | 16:15 ET | [S-1](/filings/0001493152-25-028562.md) | Registration statement | 0001493152-25-028562 |
| 2025-12-19 | 16:15 ET | [8-K](/filings/0001493152-25-028560.md) | 5.07 Shareholder vote results | 0001493152-25-028560 |
| 2025-12-05 | 16:30 ET | [8-K](/filings/0001493152-25-026383.md) | 8.01 Other events | 0001493152-25-026383 |
| 2025-11-14 | 16:09 ET | [10-Q](/filings/0001493152-25-023467.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023467 |
| 2025-11-07 | 13:13 ET | [DEF 14A](/filings/0001493152-25-021208.md) | Proxy statement, period 2025-11-07 | 0001493152-25-021208 |
| 2025-10-28 | 09:29 ET | [8-K](/filings/0001493152-25-019839.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-019839 |
| 2025-09-03 | 17:40 ET | [8-K](/filings/0001641172-25-026245.md) | 8.01 Other events | 0001641172-25-026245 |
| 2025-08-29 | 17:21 ET | [10-Q](/filings/0001641172-25-026067.md) | Quarterly report, period 2025-06-30 | 0001641172-25-026067 |
| 2025-08-29 | 17:17 ET | [10-Q](/filings/0001641172-25-026056.md) | Quarterly report, period 2025-03-31 | 0001641172-25-026056 |
| 2025-08-18 | 16:30 ET | [8-K](/filings/0001641172-25-024623.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-024623 |
| 2025-08-12 | 16:59 ET | [8-K](/filings/0001641172-25-023231.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-023231 |
| 2025-08-01 | 06:30 ET | [8-K](/filings/0001641172-25-021831.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-021831 |
| 2025-07-30 | 16:30 ET | [8-K](/filings/0001641172-25-021556.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-021556 |
| 2025-07-29 | 16:18 ET | [8-K/A](/filings/0001641172-25-021378.md) | 9.01 Financial statements and exhibits | 0001641172-25-021378 |
| 2025-07-28 | 21:44 ET | [SCHEDULE 13D/A](/filings/0000905148-25-002573.md) | Ownership report, active investor, amended | 0000905148-25-002573 |
| 2025-07-22 | 16:30 ET | [8-K](/filings/0001641172-25-020580.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-020580 |
| 2025-06-10 | 16:30 ET | [8-K](/filings/0001641172-25-014525.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-014525 |
| 2025-06-06 | 16:30 ET | [8-K](/filings/0001641172-25-014073.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-014073 |
| 2025-05-21 | 17:29 ET | [10-K/A](/filings/0001641172-25-011942.md) | Annual report, amended, period 2024-12-31 | 0001641172-25-011942 |
| 2025-05-20 | 16:52 ET | [8-K](/filings/0001641172-25-011751.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001641172-25-011751 |
| 2025-05-16 | 16:15 ET | [8-K](/filings/0001641172-25-011253.md) | 5.02 Departure or appointment of officers or directors | 0001641172-25-011253 |
| 2025-05-09 | 16:30 ET | [8-K](/filings/0001641172-25-009462.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009462 |
| 2025-05-08 | 17:28 ET | [10-K](/filings/0001641172-25-009319.md) | Annual report, period 2024-12-31 | 0001641172-25-009319 |
| 2025-05-01 | 16:15 ET | [8-K](/filings/0001641172-25-008104.md) | 8.01 Other events | 0001641172-25-008104 |
| 2025-04-23 | 17:15 ET | [8-K](/filings/0001641172-25-005884.md) | 3.01 Delisting notice | 0001641172-25-005884 |
| 2025-03-21 | 16:30 ET | [8-K](/filings/0001493152-25-011156.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-011156 |

Page 1 of 4. [Older](/companies/celu/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 09:26 ET. No prices; not investment advice.